Background Small intestinal neuroendocrine tumors (SI-NETs) are uncommon, with an annual
incidence of about 1 per 100,000 individuals. The primary tumor (PT) is generally small, …

Importance Primary tumor resection and mesenteric lymph node dissection in asymptomatic
patients with stage IV small intestinal neuroendocrine tumors (SI-NETs) are controversial. …

Background Until recently, the genetic landscape of small intestinal neuroendocrine tumors (SI-NETs)
was limited to recurrent copy number alterations, most commonly a loss on …

Background In patients with small intestinal neuroendocrine tumours (SI-NETs), serotonin
and other cytokines released from tumour cells may induce fibrosis, leading to carcinoid heart …

Peptide receptor radiotherapy (PRRT) with 177 Lu-DOTATATE has emerged as a promising
therapy for neuroendocrine tumors (NETs). This retrospective cohort study aimed to assess …

Purpose The Bethesda classification for cytology is used to classify thyroid nodules into one
of six categories, and for each category there is an implied cancer risk and also …

Objective: To investigate the prevalence and risk factors for permanent hypoparathyroidism
after total thyroidectomy for benign disease in a population-based setting with data …

Context: As a group, neuroendocrine tumors (NETs) secrete many different peptide hormones,
yet heretofore each NET patient is typically thought to produce at most one hormone that …

Background In patients with small intestinal neuroendocrine tumour (SI-NET), liver resection
or radiofrequency ablation (RFA) of liver metastases is performed for palliation of carcinoid …

Background Patients with midgut carcinoid (MGC) tumors are commonly treated with
somatostatin analogs. Adverse effects of these drugs include impairment of gallbladder function, …